🎉 M&A multiples are live!
Check it out!

AstraZeneca India Valuation Multiples

Discover revenue and EBITDA valuation multiples for AstraZeneca India and similar public comparables like Vivoryon Therapeutics, Pharming, and Galapagos.

AstraZeneca India Overview

About AstraZeneca India

AstraZeneca Pharma India Ltd is engaged in the manufacture, trading, and marketing of pharmaceutical products. Its only operating segment is Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of its revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation, Autoimmunity, Neuroscience Infection and Vaccines.


Founded

1979

HQ

India
Employees

940

Website

astrazeneca.com

Financials

Last FY Revenue $201M

Last FY EBITDA $23.2M

EV

$2.3B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

AstraZeneca India Financials

In the most recent fiscal year, AstraZeneca India achieved revenue of $201M and an EBITDA of $23.2M.

AstraZeneca India expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See AstraZeneca India valuation multiples based on analyst estimates

AstraZeneca India P&L

NTM Last FY FY 2025 FY 2026 FY 2027
Revenue XXX $201M XXX XXX XXX
Gross Profit XXX $88.2M XXX XXX XXX
Gross Margin XXX 44% XXX XXX XXX
EBITDA XXX $23.2M XXX XXX XXX
EBITDA Margin XXX 12% XXX XXX XXX
EBIT XXX $25.1M XXX XXX XXX
EBIT Margin XXX 12% XXX XXX XXX
Net Profit XXX $13.6M XXX XXX XXX
Net Margin XXX 7% XXX XXX XXX
Net Debt XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

AstraZeneca India Stock Performance

As of May 30, 2025, AstraZeneca India's stock price is INR 7965 (or $93).

AstraZeneca India has current market cap of INR 199B (or $2.3B), and EV of INR 194B (or $2.3B).

See AstraZeneca India trading valuation data

AstraZeneca India Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.3B $2.3B XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

AstraZeneca India Valuation Multiples

As of May 30, 2025, AstraZeneca India has market cap of $2.3B and EV of $2.3B.

AstraZeneca India's trades at 12.1x EV/Revenue multiple, and 93.7x EV/EBITDA.

Equity research analysts estimate AstraZeneca India's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

AstraZeneca India's P/E ratio is not available.

See valuation multiples for AstraZeneca India and 12K+ public comps

AstraZeneca India Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $2.3B XXX $2.3B XXX XXX XXX
EV (current) $2.3B XXX $2.3B XXX XXX XXX
EV/Revenue n/a XXX 12.1x XXX XXX XXX
EV/EBITDA n/a XXX 93.7x XXX XXX XXX
EV/EBIT n/a XXX 95.5x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E n/a XXX 156.6x XXX XXX XXX
EV/FCF n/a XXX 373.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get AstraZeneca India Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

AstraZeneca India Margins & Growth Rates

AstraZeneca India's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

AstraZeneca India's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

AstraZeneca India's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for AstraZeneca India and other 12K+ public comps

AstraZeneca India Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth n/a XXX n/a XXX XXX XXX
EBITDA Margin n/a XXX n/a XXX XXX XXX
EBITDA Growth n/a XXX n/a XXX XXX XXX
Rule of 40 n/a XXX n/a XXX XXX XXX
Bessemer Rule of X XXX XXX n/a XXX XXX XXX
Revenue per Employee XXX XXX $0.2M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 5% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 31% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

AstraZeneca India Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Vaccines & Immunotherapies comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

AstraZeneca India M&A and Investment Activity

AstraZeneca India acquired  XXX companies to date.

Last acquisition by AstraZeneca India was  XXXXXXXX, XXXXX XXXXX XXXXXX . AstraZeneca India acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by AstraZeneca India

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About AstraZeneca India

When was AstraZeneca India founded? AstraZeneca India was founded in 1979.
Where is AstraZeneca India headquartered? AstraZeneca India is headquartered in India.
How many employees does AstraZeneca India have? As of today, AstraZeneca India has 940 employees.
Is AstraZeneca India publicy listed? Yes, AstraZeneca India is a public company listed on BOM.
What is the stock symbol of AstraZeneca India? AstraZeneca India trades under 506820 ticker.
When did AstraZeneca India go public? AstraZeneca India went public in 2001.
Who are competitors of AstraZeneca India? Similar companies to AstraZeneca India include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of AstraZeneca India? AstraZeneca India's current market cap is $2.3B
Is AstraZeneca India profitable? Yes, AstraZeneca India is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.